Roberto Mina

Statistics

Publications

Citations

H-Index

Active since

2012

Affiliations

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino(Current)

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”

Istituti di Ricovero e Cura a Carattere Scientifico

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Fondazione IRCCS Istituto Nazionale dei Tumori

Roberto Mina is an author at Azienda Ospedaliera Citta' della Salute e della Scienza di Torino specializing in medicine, multiple myeloma treatment, and hematologic malignancy therapy.

ORCID

Publications per year

2012–2025

Publications

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro et al. · New England Journal of Medicine · 2023 · 515 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival

Antonio Palumbo, Sara Bringhen, Alessandra Larocca et al. · Journal of Clinical Oncology · 2014 · 210 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Results of the Phase III Randomized Iskia Trial: Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone Vs Carfilzomib-Lenalidomide-Dexamethasone As Pre-Transplant Induction and Post-Transplant Consolidation in Newly Diagnosed Multiple Myeloma Patients

Francesca Gay, Wilfried Roeloffzen, Meletios Α. Dimopoulos et al. · Blood · 2023 · 99 citations

Medicine, Hematology, Oncology +17

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma

Valeria Magarotto, Sara Bringhen, Massimo Offidani et al. · Blood · 2016 · 94 citations · Full text

Medicine, Hematology, Oncology +15

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study

Alessandra Larocca, Vittorio Montefusco, Sara Bringhen et al. · Blood · 2013 · 88 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

1–5 of 38